BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9548490)

  • 1. Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells.
    Weng WK; Shah N; O'Brien D; Van Ness B; LeBien TW
    J Immunol; 1997 Dec; 159(11):5502-8. PubMed ID: 9548490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linking CD40 on B cells rapidly activates nuclear factor-kappa B.
    Berberich I; Shu GL; Clark EA
    J Immunol; 1994 Nov; 153(10):4357-66. PubMed ID: 7525701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
    Miller C; Zhang M; He Y; Zhao J; Pelletier JP; Martel-Pelletier J; Di Battista JA
    J Cell Biochem; 1998 Jun; 69(4):392-413. PubMed ID: 9620167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
    Bouillie S; Barel M; Frade R
    J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
    Zerbini LF; Wang Y; Cho JY; Libermann TA
    Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome.
    Cianferoni A; Massaad M; Feske S; de la Fuente MA; Gallego L; Ramesh N; Geha RS
    J Allergy Clin Immunol; 2005 Dec; 116(6):1364-71. PubMed ID: 16337472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kappaB/Rel and AP-1.
    Ishii H; Takada K; Higuchi T; Sugiyama J
    Thromb Haemost; 2000 Oct; 84(4):712-21. PubMed ID: 11057875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase.
    Kitanaka A; Ito C; Coustan-Smith E; Campana D
    J Immunol; 1997 Jul; 159(1):184-92. PubMed ID: 9200454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-kappaB signaling in human gastric carcinoma cells.
    Baek MK; Kim MH; Jang HJ; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
    Oncol Rep; 2008 Dec; 20(6):1569-75. PubMed ID: 19020743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of RANTES and IL-8 expression in lung adenocarcinoma cells.
    Henriquet C; Gougat C; Combes A; Lazennec G; Mathieu M
    Lung Cancer; 2007 May; 56(2):167-74. PubMed ID: 17207890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin produces myogenesis in C2C12 myoblasts by induction of NF-kappaB and downregulation of AP-1 activities.
    Conejo R; Valverde AM; Benito M; Lorenzo M
    J Cell Physiol; 2001 Jan; 186(1):82-94. PubMed ID: 11147817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The signaling activity of murine CD19 is regulated during cell development.
    Krop I; Shaffer AL; Fearon DT; Schlissel MS
    J Immunol; 1996 Jul; 157(1):48-56. PubMed ID: 8683154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
    Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
    Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
    Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
    Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inducible nuclear expression of NF-kappa B in primary B cells stimulated through the surface Ig receptor.
    Liu JL; Chiles TC; Sen RJ; Rothstein TL
    J Immunol; 1991 Mar; 146(5):1685-91. PubMed ID: 1993849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
    Ishiura N; Nakashima H; Watanabe R; Kuwano Y; Adachi T; Takahashi Y; Tsubata T; Okochi H; Tamaki K; Tedder TF; Fujimoto M
    Eur J Immunol; 2010 Apr; 40(4):1192-204. PubMed ID: 20101619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.